
Nemaura Medical Inc
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- $0.35
- Today's High:
- $0.3969
- Open Price:
- $0.3969
- 52W Low:
- $0.35
- 52W High:
- $3.43
- Prev. Close:
- $0.4
- Volume:
- 87104
Company Statistics
- Market Cap.:
- $11.56 million
- Book Value:
- -0.498
- Revenue TTM:
- $77044
- Operating Margin TTM:
- -11780.43%
- Gross Profit TTM:
- $-1476392
- Profit Margin:
- 0%
- Return on Assets TTM:
- -40.28%
- Return on Equity TTM:
- -724.44%
Company Profile
Nemaura Medical Inc had its IPO on 2016-03-04 under the ticker symbol NMRD.
The company operates in the Healthcare sector and Medical Devices industry. Nemaura Medical Inc has a staff strength of 36 employees.
Stock update
Shares of Nemaura Medical Inc opened at $0.4 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.35 - $0.4, and closed at $0.35.
This is a -12.5% slip from the previous day's closing price.
A total volume of 87,104 shares were traded at the close of the day’s session.
In the last one week, shares of Nemaura Medical Inc have slipped by -22.74%.
Nemaura Medical Inc's Key Ratios
Nemaura Medical Inc has a market cap of $11.56 million, indicating a price to book ratio of 122.5612 and a price to sales ratio of 71.6132.
In the last 12-months Nemaura Medical Inc’s revenue was $77044 with a gross profit of $-1476392 and an EBITDA of $-8632643. The EBITDA ratio measures Nemaura Medical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Nemaura Medical Inc’s operating margin was -11780.43% while its return on assets stood at -40.28% with a return of equity of -724.44%.
In Q2, Nemaura Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.
Nemaura Medical Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.51 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nemaura Medical Inc’s profitability.
Nemaura Medical Inc stock is trading at a EV to sales ratio of 91.4287 and a EV to EBITDA ratio of -6.0732. Its price to sales ratio in the trailing 12-months stood at 71.6132.
Nemaura Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $14.56 million
- Total Liabilities
- $22.27 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $100412
- Dividend Payout Ratio
- 0%
Nemaura Medical Inc ended 2023 with $14.56 million in total assets and $0 in total liabilities. Its intangible assets were valued at $14.56 million while shareholder equity stood at $-11814198.00.
Nemaura Medical Inc ended 2023 with $0 in deferred long-term liabilities, $22.27 million in other current liabilities, 28899.00 in common stock, $-51875211.00 in retained earnings and $0 in goodwill. Its cash balance stood at $10.11 million and cash and short-term investments were $10.11 million. The company’s total short-term debt was $16,942,500 while long-term debt stood at $119477.00.
Nemaura Medical Inc’s total current assets stands at $13.54 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $409648.00 compared to accounts payable of $326641.00 and inventory worth $1.75 million.
In 2023, Nemaura Medical Inc's operating cash flow was $0 while its capital expenditure stood at $100412.
Comparatively, Nemaura Medical Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- $0.35
- 52-Week High
- $3.43
- 52-Week Low
- $0.35
- Analyst Target Price
- $7.67
Nemaura Medical Inc stock is currently trading at $0.35 per share. It touched a 52-week high of $3.43 and a 52-week low of $3.43. Analysts tracking the stock have a 12-month average target price of $7.67.
Its 50-day moving average was $0.77 and 200-day moving average was $1.08 The short ratio stood at 1.17 indicating a short percent outstanding of 0%.
Around 4906.6% of the company’s stock are held by insiders while 1124.9% are held by institutions.
Frequently Asked Questions About Nemaura Medical Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.